During the past decade, California Cancer Care Inc conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 13 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "California Cancer Care Inc" #1 sponsor was "Eastern Cooperative Oncology Group" with 4 trials, followed by "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "Morphotek" with 3 trials sponsored, "Novartis Pharmaceuticals" with 2 trials sponsored and "Prologue Research International" with 2 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "California Cancer Care Inc" #1 collaborator was "National Cancer Institute (NCI)" with 10 trials as a collaborator, "Aptuit" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator and "Eisai Europe Ltd. (United Kingdom)" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "California Cancer Care Inc" are "Colorectal Cancer" (7 trials), "Breast Cancer" (6 trials), "Ovarian Cancer" (4 trials), "Lymphoma" (3 trials) and "Breast Neoplasms" (2 trials). Many other conditions were trialed in "California Cancer Care Inc" in a lesser frequency.

Most popular intervention types in "California Cancer Care Inc" are "Drug" (33 trials), "Biological" (7 trials), "Other" (3 trials), "Procedure" (3 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "fluorouracil" (5 trials), "bevacizumab" (4 trials), "leucovorin calcium" (4 trials), "oxaliplatin" (4 trials) and "Paclitaxel" (3 trials). Other intervention names were less common.

The vast majority of trials in "California Cancer Care Inc" are 23 trials for "All" genders, 10 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "California Cancer Care Inc". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in California Cancer Care Inc, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in California Cancer Care Inc, 3 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".